Johnson & Johnson: Recent Advancements in Diagnosis & Management of X-linked Retinitis Pigmentosa
Location: 212
Date & Time: Friday, 20 September, 09:45 - 10:45 CEST
Chairperson(s): B. Leroy, BELGIUM
Speakers:
Presentations:
B. Leroy BELGIUM
09:45 Introduction
I. Audo FRANCE
09:48 Why is early diagnosis of XLRP important?
G. Black UK
10:00 What are the current and future prospects for genetic testing in XLRP?
P. Herrmann GERMANY
10:12 How will the XLRP treatment landscape evolve over the next years?
B. Leroy BELGIUM,
I. Audo FRANCE,
G. Black UK,
P. Herrmann GERMANY
10:24 Group discussion
This is a promotional symposium for HCPs only. Presentations and materials disclosed during the event are subject to Intellectual Property Rights. Total or partial reproduction or use of this content requires prior AbbVie authorization. Furthermore, in order to comply with the regulations regarding the promotion of medicines, we ask you not to share its contents on your social networks. Please do not distribute in media, or communication channels aimed at the general public.